metformin has been researched along with Fibrosarcoma in 6 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the effect of metformin and caffeine on fibrosarcoma in hamsters." | 7.88 | Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters. ( Čapo, I; Lalošević, D; Miljković, D; Popović, DJ; Popović, JK; Popović, KJ, 2018) |
| "We investigated the effect of metformin on an in vivo solid tumor model of fibrosarcoma in hamsters." | 7.85 | Effect of metformin on fibrosarcoma in hamsters. ( Čapo, I; Lalošević, D; Miljković, D; Popović, DJ; Popović, JK; Popović, KJ, 2017) |
| "Metformin was intraperitoneally (i." | 5.72 | The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice. ( Jang, WI; Kim, D; Kim, E; Kim, H; Kim, MS; Kim, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Popović, KJ | 4 |
| Popović, DJ | 4 |
| Miljković, D | 4 |
| Popović, JK | 4 |
| Lalošević, D | 4 |
| Poša, M | 1 |
| Čapo, I | 4 |
| Kim, H | 1 |
| Kim, D | 1 |
| Kim, W | 1 |
| Kim, E | 1 |
| Jang, WI | 1 |
| Kim, MS | 1 |
| Nilsson, S | 1 |
| Huelsenbeck, J | 1 |
| Fritz, G | 1 |
6 other studies available for metformin and Fibrosarcoma
| Article | Year |
|---|---|
Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Disulfiram; Female; Fibrosarc | 2021 |
The Efficacy of Radiation is Enhanced by Metformin and Hyperthermia Alone or Combined Against FSaII Fibrosarcoma in C3H Mice.
Topics: Animals; B7-H1 Antigen; Fibrosarcoma; Hyperthermia, Induced; Hypoxia-Inducible Factor 1, alpha Subun | 2022 |
Co-treatment with nitroglycerin and metformin exhibits physicochemically and pathohistologically detectable anticancer effects on fibrosarcoma in hamsters.
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Fibrosarcoma; Male; Mesocricetus; | 2020 |
Effect of metformin on fibrosarcoma in hamsters.
Topics: Animals; Blood Glucose; Cell Line; Cricetinae; Female; Fibrosarcoma; Ki-67 Antigen; Male; Metformin; | 2017 |
Caffeine induces metformin anticancer effect on fibrosarcoma in hamsters.
Topics: Animals; Antineoplastic Agents; Caffeine; Cricetinae; Drug Synergism; Female; Fibrosarcoma; Male; Me | 2018 |
Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; | 2011 |